The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

Bone marrow transplantation is a costly procedure. Depending on the type of transplant the rate may vary from ₹7 lakh to ₹50 ...

An estimated 12,000 children are born with thalassemia major, a severe form of the disease, in India each year, accounting ...

Discover Agios Pharmaceuticals' Q4 2024 earnings highlights, growth plans for Pyrukynd in thalassemia & sickle cell, and insights on safety, clinical ...

Commissioner Sargodha Division Jahanzeb Awan visited the Thalassemia and Hemophilia Centre at Hilal-e-Ahmer Hospital to review the ...

While the S&P 500 has soared nearly 21% over the last 12 months, healthcare stocks as a group are barely in positive ...

A Thalassemia screening desk has been inaugurated at the NADRA center in Sukkur on Saturday marking a significant step ...

DKMS Foundation India inaugurates new BMT unit in Ahmedabad, providing hope and treatment for thalassemia patients in Gujarat ...

Agios Pharmaceuticals Inc (AGIO) reports a 51% increase in net Pyrukynd revenue and outlines promising future launches and ...

As India remains the thalassemia capital of the world, the Thalassemia Patients Advocacy Group (TPAG) has written an open ...

A Thalassemia screening desk has been inaugurated at the NADRA centre in Sukkur on Saturday marking a significant step ...

Global Thalassemia Market Global Thalassemia Market Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Thalassemia Market by Treatment Type, by Type, by Distribution Channel, and by Region" report has ...